Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Short-term Investments (2020 - 2026)

Oric Pharmaceuticals filings provide 7 years of Short-term Investments readings, the most recent being $225.5 million for Q1 2026.

  • Quarterly Short-term Investments rose 46.08% to $225.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $225.5 million through Mar 2026, up 46.08% year-over-year, with the annual reading at $235.8 million for FY2025, 19.98% up from the prior year.
  • Short-term Investments hit $225.5 million in Q1 2026 for Oric Pharmaceuticals, down from $235.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $260.4 million in Q1 2024 and bottomed at $122.0 million in Q1 2022.
  • Average Short-term Investments over 5 years is $191.9 million, with a median of $196.6 million recorded in 2024.
  • The largest annual shift saw Short-term Investments skyrocketed 1170.68% in 2022 before it plummeted 40.71% in 2025.
  • Oric Pharmaceuticals' Short-term Investments stood at $139.4 million in 2022, then skyrocketed by 32.54% to $184.8 million in 2023, then increased by 6.36% to $196.6 million in 2024, then increased by 19.98% to $235.8 million in 2025, then dropped by 4.36% to $225.5 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Short-term Investments are $225.5 million (Q1 2026), $235.8 million (Q4 2025), and $237.5 million (Q3 2025).